Characteristics of Eye Disorders Induced by Atypical Antipsychotics: a Real-world Study from 2016 to 2022 Based on Food and Drug Administration Adverse Event Reporting System

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Aug 19

PMID 39156610

Authors

Chao Mu

Li Chen

Affiliations

Soon will be listed here.

Abstract

Background: Common atypical antipsychotics include risperidone, paliperidone, olanzapine, lurasidone, quetiapine, clozapine, aripiprazole, ziprasidone, asenapine, brexpiprazole, and cariprazine. Previous studies on ocular adverse reactions of antipsychotics were mainly focused on typical antipsychotics. Systematic research on atypical antipsychotics remains limited.

Objective: This study aimed to evaluate the potential risks of different atypical antipsychotics causing ocular side effects by mining the Food and Drug Administration Adverse Event Reporting System (FAERS) database.

Methods: Extract reports from the FAERS from the first quarter of 2016 to the fourth quarter of 2022 were obtained. Data mining of eye disorders associated with atypical antipsychotics was carried out using The Reporting Odds Ratio (ROR) method and The Medicines and Healthcare Products Regulatory Agency (MHRA) method to determine positive signals.

Results: FAERS reports for 9913783 cases were included in these 28 quarters. 64 defined ocular adverse events were classified into 10 categories according to High-Level Group Terms (HLGT).

Conclusions: There were differences in the types and severity of ocular-related adverse events associated with atypical antipsychotics. Ocular neuromuscular-related adverse events were found among all 11 atypical antipsychotics. Olanzapine had the highest signal intensity in oculogyric crisis. Aripiprazole had the highest signal strength in blepharospasm. Cariprazine was associated with cataract-related ocular adverse reactions. In terms of the types of adverse events, our study found that aripiprazole was associated with 28 types of ocular adverse events, followed by quetiapine. Clozapine was only associated with two types of ocular adverse events.

References

Suthar N, Nebhinani N . Aripiprazole induced neck dystonia and oculogyric crisis. Asian J Psychiatr. 2018; 31:94-95. DOI: 10.1016/j.ajp.2018.01.022. View

Ceylan E, Ozer M, Yilmaz Y, Kartal B, Ekinci D, Cinici E . The ocular surface side effects of an anti-psychotic drug, clozapine. Cutan Ocul Toxicol. 2015; 35(1):62-6. DOI: 10.3109/15569527.2015.1018387. View

Wilson A, Filatov A, Azhar M, Swerdloff M, Husain Wilson S . Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female. Cureus. 2020; 12(7):e9100. PMC: 7417033. DOI: 10.7759/cureus.9100. View

Nowrouzi A, Kafiabasabadi S, Rodriguez-Calzadilla M, Benitez-Del-Castillo J, Soto-Guerrero A, Diaz-Ramos A . Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report. J Med Case Rep. 2021; 15(1):307. PMC: 8164284. DOI: 10.1186/s13256-021-02865-8. View

Shimizu E, Otsuka A, Hashimoto K, Iyo M . Blepharospasm associated with olanzapine: a case report. Eur Psychiatry. 2004; 19(6):389. DOI: 10.1016/j.eurpsy.2004.06.010. View

Kozlova A, McCanna C, Gelman R . Risperidone-related bilateral cystoid macular edema: a case report. J Med Case Rep. 2019; 13(1):59. PMC: 6415337. DOI: 10.1186/s13256-019-1978-y. View

Li J, Tripathi R, Tripathi B . Drug-induced ocular disorders. Drug Saf. 2008; 31(2):127-41. DOI: 10.2165/00002018-200831020-00003. View

Ruiz De Villa A, Haider A, Frimer L, Bazikian Y . Oculogyric Crisis in the Setting of Low Dose Risperidone and Benztropine Mesylate Use in a Patient With Schizophrenia: A Case Report and Review of Literature. Cureus. 2022; 14(7):e27217. PMC: 9399662. DOI: 10.7759/cureus.27217. View

Riccobene T, Riesenberg R, Yeung P, Earley W, Hankinson A . Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia. J Child Adolesc Psychopharmacol. 2022; 32(8):434-443. DOI: 10.1089/cap.2021.0139. View

10.

Praveen Kumar K, Chiranjeevi P, Alam M . Aripiprazole-induced transient myopia: A rare entity. Indian J Ophthalmol. 2017; 66(1):130-131. PMC: 5778548. DOI: 10.4103/ijo.IJO_907_16. View

11.

Desarkar P, Das A, Sinha V . Olanzapine-induced oculogyric crisis. Aust N Z J Psychiatry. 2006; 40(4):374. DOI: 10.1111/j.1440-1614.2006.01805.x. View

12.

van Renterghem L, Titeca K, Crunelle C, Geerts P, Matthys F . [Oculogyric crisis as an isolated extrapyramidal symptom of auto-intoxication with risperidone]. Tijdschr Psychiatr. 2019; 61(9):649-653. View

13.

Das S, Agrawal A . Lurasidone-induced Oculogyric Crisis. Indian J Psychol Med. 2017; 39(5):719-720. PMC: 5688914. DOI: 10.4103/IJPSYM.IJPSYM_266_17. View

14.

Jauhar S, Johnstone M, McKenna P . Schizophrenia. Lancet. 2022; 399(10323):473-486. DOI: 10.1016/S0140-6736(21)01730-X. View

15.

Angelaki M, Alexiou E, Igoumenou A, Alevizopoulos G . Frequency of sexual dysfunction in outpatients with severe mental illness in Greece. Front Psychiatry. 2023; 14:1227218. PMC: 10503055. DOI: 10.3389/fpsyt.2023.1227218. View

16.

Matsuo M, Sano I, Ikeda Y, Fujihara E, Tanito M . Intraoperative floppy-iris syndrome associated with use of antipsychotic drugs. Can J Ophthalmol. 2016; 51(4):294-296. DOI: 10.1016/j.jcjo.2016.02.008. View

17.

Davis S, Zabotka L, Desai R, Wang S, Maro J, Coughlin K . Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review. Drug Saf. 2023; 46(8):725-742. PMC: 11635839. DOI: 10.1007/s40264-023-01325-0. View

18.

Gowda G, Hegde A, Shanbhag V, Narayanaswamy J, Jaisoorya T . Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series. Asian J Psychiatr. 2017; 25:188-190. DOI: 10.1016/j.ajp.2016.11.002. View

19.

Mullen A . Risperidone and tardive dyskinesia: a case of blepharospasm. Aust N Z J Psychiatry. 2000; 34(5):879-80. DOI: 10.1080/j.1440-1614.2000.0822m.x. View

20.

Manousaridis K, Gupta R . Risperidone-related bilateral cystoid macular oedema. Graefes Arch Clin Exp Ophthalmol. 2012; 251(3):1037-8. DOI: 10.1007/s00417-012-2071-z. View